Ahuja, N, Cole, AJ (2009) Hyperthermia syndromes in
psychiatry. Advances in Psychiatric
Treatment, 15: 181–91.
Boyer, E, Shannon, M (2005) The serotonin
syndrome. New England Journal of
Medicine, 352: 1112–20.
Buckley, AB, Dawson, AH, Isbister, GK (2014) Serotonin
syndrome. BMJ, 348:
Cauli, O, Morelli, M (2005) Caffeine and the dopaminergic
system. Behavioural Pharmacology,
Chander, WP, Singh, N, Mukhiya, GK (2011) Serotonin syndrome in maintenance
haemodialysis patients following sertraline treatment for
depression. Journal of the Indian Medical
Association, 109: 36–7.
Chang, TW, Castle, DJ (2004) Layer upon layer,
thermoregulation in schizophrenia. Schizophrenia
Research, 69: 149–57.
Chechani, V (2002) Serotonin syndrome presenting as
hypotonic coma and apnoea: potentially fatal complications of selective
serotonin reuptake inhibitor therapy. Critical
Care Medicine, 30: 473–6.
Cooper, BE, Sejnowski, CA (2013) Serotonin syndrome: recognition
and treatment. AACN Advanced Critical
Copeland, J, Dillon, P, Gascoigne, M (2006) Ecstasy and the concomitant use
of pharmaceuticals. Addictive Behaviors,
Demyttenaere, K, Haddad, P (2000) Compliance with antidepressant
therapy and antidepressant discontinuation symptoms.
Acta Psychiatrica Scandinavica Supplementum,
Dunkley, EJC, Isbister, GK, Sibbritt, D et al (2003) The Hunter Serotonin
Toxicity Criteria: simple and accurate diagnostic decision rules for
serotonin toxicity. QJM,
Ener, RA, Sharon, B, Meglathery, MD et al (2003) Serotonin syndrome and
other serotonergic disorders. Pain
Evans, RW, Tepper, SJ, Shapiro, RE et al (2010) The FDA alert on serotonin
syndrome with use of triptans combined with selective serotonin reuptake
inhibitors or selective serotonin-norepinephrine reuptake inhibitors:
American Headache Society position paper.
Headache, 50: 1089–99.
Ferrari, A (2006) Headache: one of the most common
and troublesome adverse reactions to drugs.
Current Drug Safety, 1:
Fox, MA, Jensen, CL, Gallagher, PS et al (2007) Receptor mediation of
exaggerated responses to serotonin-enhancing drugs in serotonin
transporter (SERT)-deficient mice.
Fugate, JE, White, RD, Rabinstein, AA (2014) Serotonin syndrome after
therapeutic hypothermia for cardiac arrest: a case
series. Resuscitation, 85:
Gillman, PK (2005) Monoamine oxidase inhibitors,
opioid analgesics and serotonin toxicity. British
Journal of Anaesthesia, 95:
Gillman, PK (2010a) Triptans, serotonin agonists,
and serotonin syndrome (serotonin toxicity): a review.
Headache, 50: 264–72.
Gillman, PK (2010b) CNS toxicity involving methylene
blue: the exemplar for understanding and predicting drug interactions
that precipitate serotonin toxicity. Journal of
Haddad, PM, Dursun, SM (2008) Neurological complications of
psychiatric drugs: clinical features and management.
Human Psychopharmacology: Clinical and Experimental,
Hegerl, U, Bottlender, R, Gallinat, J et al (1998) The serotonin syndrome
scale: first results on validity. European
Archives of Psychiatry and Clinical Neuroscience,
Herraiz, T, Chapparo, C (2006) Human monoamine oxidase
inhibition by coffee and beta-carbolines norharman and harman isolated
from coffee. Life Sciences,
Iqbal, MM, Miles, JB, Kaplan, J et al (2012) Overview of serotonin
syndrome. Annals of Clinical Psychiatry,
Isbister, IK, Buckley, NA, Whyte, IM (2007) Serotonin toxicity: a practical
guide to diagnosis and treatment. Medical Journal
of Australia, 187: 361–5.
Jacobs, BL (1974) Effect of two dopamine receptor
blockers on a serotonin-mediated behavioural syndrome in
rats. European Journal of Pharmacology,
Jones, SL, Athan, E, O'Brien, D (2004) Serotonin syndrome due to
co-administration of linezolid and venlafaxine.
Journal of Antimicrobial Chemotherapy,
Kiani, J, Imam, SZ (2007) Medicinal importance of
grapefruit juice and its interactions with various drugs.
Nutrition Journal, 6:
Krishnamoorthy, S, Ma, Z, Zhang, G et al (2010) Involvement of 5-HT2A
receptors in the serotonin syndrome caused by excessive 5-HT efflux in
the rat brain. Clinical Pharmacology and
Toxicology, 107: 830–41.
Lane, RM (1998) SSRI-induced extrapyramidal side
effects and akathisia: implications for treatment.
Journal of Psychopharmacology, 12:
Lee, AJ, Chan, WK, Harralson, AF et al (1999) The effects of grapefruit
juice on sertraline metabolism: an in vitro and in vivo
study. Clinical Therapeutics,
Lee, YC, Chen, PP (2010) A review of SSRIs and SNRIs in
neuropathic pain. Expert Opinion on
Pharmacotherapy, 11: 2813–25.
Lingam, R, Scott, J (2002) Treatment non-adherence in
affective disorders. Acta Psychiatrica
Scandinavica, 105: 164–72.
Lynch, T, Price, A (2007) The effect of cytochrome P450
metabolism on drug response, interactions and adverse
effects. American Family Physician,
Monte, A, Chuang, R, Bodmer, M (2010) Dextromethorphan,
chlorpheniramine and serotonin toxicity: case report and systemic
literature review. British Journal of Clinical
Pharmacology, 70: 794–8.
Morris, R, Matthes, J (2015) Serotonin syndrome in a
breast-fed neonate. BMJ Case Reports,
DOI: 10.1136/bcr-2015–209418 (published online 6 May).
Morrish, PK (2014) Serotonin
syndrome. BMJ, 348:
Odagaki, Y (2009) Atypical neuroleptic malignant
syndrome or serotonin toxicity associated with atypical
Current Drug Safety, 4:
Okamoto, N, Sakomoto, K, Yamada, M (2012) Transient serotonin syndrome by
concurrent use of electroconvulsive therapy and selective serotonin
reuptake inhibitor: a case report and review of the
literature. Case Reports in Psychiatry,
2012: article ID 215214.
Park, SH, Wackermah, RC, Stimmel, GL (2014) Serotonin syndrome: is it a
reason to avoid the use of tramadol with antidepressants?
Journal of Pharmacy Practice, 27:
Prakash, S, Belani, P, Trivedi, A (2014) Headache as a presenting feature
in patients with serotonin syndrome: a case series.
Radomski, JW, Dursun, SM, Reveley, MA et al (1999) An exploratory approach to
the serotonin syndrome: an update of clinical phenomenology and revised
diagnostic criteria. Medical Hypotheses,
Shaikh, Z, Krueper, S, Malins, T (2011) Serotonin syndrome: take a close
look at the unwell surgical patient. Annals of
The Royal College of Surgeons of England, 93:
Shee, JC (1960) Dangerous potentiation of
pethidine by iproniazid and its treatment.
BMJ, 2: 507–9.
Shioda, K, Nisijima, K, Nishida, S et al (2004) Possible serotonin syndrome
arising from an interaction between caffeine and serotonergic
antidepressants. Human Psychopharmacology:
Clinical and Experimental, 19:
Silins, E, Copeland, J, Dillon, P (2007) Qualitative review of serotonin
syndrome, ecstasy (MDMA) and the use of other serotonergic substances:
hierarchy of risk. Australian & New Zealand
Journal of Psychiatry, 41:
Steele, D, Keltner, NL, McGuiness, TM (2011) Are neuroleptic malignant
syndrome and serotonin syndrome the same syndrome?
Perspectives in Psychiatric Care, 47:
Sternbach, H (1991) The serotonin
syndrome. American Journal of
Psychiatry, 148: 705–13.
Sun-Edelstein, C, Tepper, SJ, Shapiro, RE (2008) Drug-induced serotonin syndrome:
a review. Expert Opinion on Drug Safety,
Tomaselli, G, Modestin, J (2004) Repetition of serotonin syndrome
after re-exposure to SSRI: a case report. Journal
of Pharmacopsychiatry, 37:
Volpie-Abadie, J, Kaye, A, Kaye, D (2013) Serotonin
syndrome. Ochsner Journal,
Zhou, S, Chan, E, Pan, SQ (2004) Pharmacokinetic interactions of
drugs with St John's Wort. Journal of
Zhou, SF (2009) Polymorphisms of human cytochrome
P450 2D6 and its clinical significance: Part 1.
Clinical Pharmacokinetics, 48: